Kirsty Wydenbach Challenges and advice for CID trials, and how COVID-19 has impacted the MHRA. by National Institute for Health and Care Research published on 2021-01-11T13:56:45Z Dr Kirsty Wydenbach deputy unit manager and senior medical assessor at the clinical trials unit in the MHRA Challenges and advice for complex innovative design trials, and how COVID-19 has impacted on the MHRAs approach. Transcript:https://docs.google.com/document/d/1HS-c3mR-B4m3RCtRpWHb5kIS8Xv90XJ2IIReWOg4fpw/edit?usp=sharing Genre Learning